Factors associated with attendance at clinical follow-up of a cohort with screen-detected type 2 diabetes: ADDITION-Denmark

Annette Danielsen Jensen; Signe Toft Andersen; Morten Charles; Lasse Bjerg; Daniel Rinse Witte; Bibi Gram; Marit Eika Jørgensen; Annelli Sandbæk; Else Marie Dalsgaard

doi:10.1016/j.pcd.2019.09.001

Factors associated with attendance at clinical follow-up of a cohort with screen-detected type 2 diabetes: ADDITION-Denmark

Annette Danielsen Jensen
, Signe Toft Andersen^*
, Morten Charles
, Lasse Bjerg
, Daniel Rinse Witte
, Bibi Gram
, Marit Eika Jørgensen
, Annelli Sandbæk
, Else Marie Dalsgaard

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

Aims: To determine the association between concurrent overall burden of disease, cardiovascular disease, cancer, self-rated health, HbA_1c levels, and attendance at clinical follow-up of the Danish arm of the ADDITION-study. Methods: Logistic regression models were used to study factors proposed being associated with attendance in clinical follow-up. We used data from clinical examinations, questionnaires and national registers at a time-point near the follow-up examination. Results: A total of 1119 participants were eligible for the follow-up conducted a median of 12.8 years (IQR 11.6; 13.4) after type 2 diabetes diagnosis by screening. Concurrent high burden of disease was associated with lower attendance (OR 0.6 (95% CI: 0.4; 0.9) for high-versus no burden of disease). Concurrent cardiovascular disease and cancer showed no statistically significant association with attendance (OR 1.0 (95% CI: 0.7; 1.4)) and (OR 0.8 (95% CI: 0.6; 1.1) for (disease versus no disease). Similarly, self-rated health (OR 0.7 (95% CI: 0.5; 1.0) poor-versus good self-rated health) and HbA_1c levels (OR 1.0 (95% CI: 0.9; 1.2 unit = 10 mmol/mol)) were not statistically significant associated with attendance. Conclusions: This study showed a lower attendance in clinical follow-up after nearly 13 years among individuals with concurrent high burden of disease. No associations were found between concurrent CVD, cancer, self-rated health and Hba_1c levels and attendance.

Originalsprog	Engelsk
Tidsskrift	Primary Care Diabetes
Vol/bind	14
Udgave nummer	3
Sider (fra-til)	239-245
ISSN	1751-9918
DOI	https://doi.org/10.1016/j.pcd.2019.09.001
Status	Udgivet - jun. 2020

Finansiering

The ADDITION-Denmark study was conducted in accordance with the principles of the Helsinki Declaration of 1996, and approved by the Central Denmark Region Committees on Health Research Ethics (approval no. 20000183 and 1-10-72-63-15). All participants gave written informed consent at baseline and at follow-up. Data was handled according to the rules from the Danish Data Protection Agency. The project is registered as part of the research projects, covered by the common university notification of the Danish Data Protection Agency on processing personal data, carried out by the university, the Danish Data Protection Agency’s journal no: 2015-57-0002, Aarhus University’s journal no: 62908, serial number 185. 2.5 The ADDITION-Denmark study was funded by the National Health Services in the former counties of Copenhagen, Aarhus, Ringkøbing, Ribe and South Jutland, The Danish Council for Strategic Research , The Danish Research Foundation for General Practice, the Novo Nordisk Foundation, The Danish Center for Evaluation and Health Technology Assessment , The Fund of the Danish National Board of Health , The Danish Medical Research Council , Aarhus University Research Foundation , Novo Nordisk Scandinavia AB , Novo Nordisk UK , ASTRA Denmark, Pfizer Denmark, GlaxoSmithKline Pharma Denmark, Servier Denmark A/S and HemoCue Denmark A/S.

Dokumenter og links

10.1016/j.pcd.2019.09.001

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{adcf2475ca26410bb7f54bf1b6277d9f,

title = "Factors associated with attendance at clinical follow-up of a cohort with screen-detected type 2 diabetes: ADDITION-Denmark",

abstract = "Aims: To determine the association between concurrent overall burden of disease, cardiovascular disease, cancer, self-rated health, HbA1c levels, and attendance at clinical follow-up of the Danish arm of the ADDITION-study. Methods: Logistic regression models were used to study factors proposed being associated with attendance in clinical follow-up. We used data from clinical examinations, questionnaires and national registers at a time-point near the follow-up examination. Results: A total of 1119 participants were eligible for the follow-up conducted a median of 12.8 years (IQR 11.6; 13.4) after type 2 diabetes diagnosis by screening. Concurrent high burden of disease was associated with lower attendance (OR 0.6 (95\% CI: 0.4; 0.9) for high-versus no burden of disease). Concurrent cardiovascular disease and cancer showed no statistically significant association with attendance (OR 1.0 (95\% CI: 0.7; 1.4)) and (OR 0.8 (95\% CI: 0.6; 1.1) for (disease versus no disease). Similarly, self-rated health (OR 0.7 (95\% CI: 0.5; 1.0) poor-versus good self-rated health) and HbA1c levels (OR 1.0 (95\% CI: 0.9; 1.2 unit = 10 mmol/mol)) were not statistically significant associated with attendance. Conclusions: This study showed a lower attendance in clinical follow-up after nearly 13 years among individuals with concurrent high burden of disease. No associations were found between concurrent CVD, cancer, self-rated health and Hba1c levels and attendance.",

keywords = "Comorbidity, Diabetes mellitus type 2, Follow-up studies",

author = "Jensen, \{Annette Danielsen\} and Andersen, \{Signe Toft\} and Morten Charles and Lasse Bjerg and Witte, \{Daniel Rinse\} and Bibi Gram and J{\o}rgensen, \{Marit Eika\} and Annelli Sandb{\ae}k and Dalsgaard, \{Else Marie\}",

year = "2020",

month = jun,

doi = "10.1016/j.pcd.2019.09.001",

language = "English",

volume = "14",

pages = "239--245",

journal = "Primary Care Diabetes",

issn = "1751-9918",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Factors associated with attendance at clinical follow-up of a cohort with screen-detected type 2 diabetes

T2 - ADDITION-Denmark

AU - Jensen, Annette Danielsen

AU - Andersen, Signe Toft

AU - Charles, Morten

AU - Bjerg, Lasse

AU - Witte, Daniel Rinse

AU - Gram, Bibi

AU - Jørgensen, Marit Eika

AU - Sandbæk, Annelli

AU - Dalsgaard, Else Marie

PY - 2020/6

Y1 - 2020/6

N2 - Aims: To determine the association between concurrent overall burden of disease, cardiovascular disease, cancer, self-rated health, HbA1c levels, and attendance at clinical follow-up of the Danish arm of the ADDITION-study. Methods: Logistic regression models were used to study factors proposed being associated with attendance in clinical follow-up. We used data from clinical examinations, questionnaires and national registers at a time-point near the follow-up examination. Results: A total of 1119 participants were eligible for the follow-up conducted a median of 12.8 years (IQR 11.6; 13.4) after type 2 diabetes diagnosis by screening. Concurrent high burden of disease was associated with lower attendance (OR 0.6 (95% CI: 0.4; 0.9) for high-versus no burden of disease). Concurrent cardiovascular disease and cancer showed no statistically significant association with attendance (OR 1.0 (95% CI: 0.7; 1.4)) and (OR 0.8 (95% CI: 0.6; 1.1) for (disease versus no disease). Similarly, self-rated health (OR 0.7 (95% CI: 0.5; 1.0) poor-versus good self-rated health) and HbA1c levels (OR 1.0 (95% CI: 0.9; 1.2 unit = 10 mmol/mol)) were not statistically significant associated with attendance. Conclusions: This study showed a lower attendance in clinical follow-up after nearly 13 years among individuals with concurrent high burden of disease. No associations were found between concurrent CVD, cancer, self-rated health and Hba1c levels and attendance.

AB - Aims: To determine the association between concurrent overall burden of disease, cardiovascular disease, cancer, self-rated health, HbA1c levels, and attendance at clinical follow-up of the Danish arm of the ADDITION-study. Methods: Logistic regression models were used to study factors proposed being associated with attendance in clinical follow-up. We used data from clinical examinations, questionnaires and national registers at a time-point near the follow-up examination. Results: A total of 1119 participants were eligible for the follow-up conducted a median of 12.8 years (IQR 11.6; 13.4) after type 2 diabetes diagnosis by screening. Concurrent high burden of disease was associated with lower attendance (OR 0.6 (95% CI: 0.4; 0.9) for high-versus no burden of disease). Concurrent cardiovascular disease and cancer showed no statistically significant association with attendance (OR 1.0 (95% CI: 0.7; 1.4)) and (OR 0.8 (95% CI: 0.6; 1.1) for (disease versus no disease). Similarly, self-rated health (OR 0.7 (95% CI: 0.5; 1.0) poor-versus good self-rated health) and HbA1c levels (OR 1.0 (95% CI: 0.9; 1.2 unit = 10 mmol/mol)) were not statistically significant associated with attendance. Conclusions: This study showed a lower attendance in clinical follow-up after nearly 13 years among individuals with concurrent high burden of disease. No associations were found between concurrent CVD, cancer, self-rated health and Hba1c levels and attendance.

KW - Comorbidity

KW - Diabetes mellitus type 2

KW - Follow-up studies

U2 - 10.1016/j.pcd.2019.09.001

DO - 10.1016/j.pcd.2019.09.001

M3 - Journal article

C2 - 31587895

AN - SCOPUS:85072760225

SN - 1751-9918

VL - 14

SP - 239

EP - 245

JO - Primary Care Diabetes

JF - Primary Care Diabetes

IS - 3

ER -

Factors associated with attendance at clinical follow-up of a cohort with screen-detected type 2 diabetes: ADDITION-Denmark

Abstract

Finansiering

Dokumenter og links

SDU link

Fingeraftryk

Citationsformater